Rapport Therapeutics, Inc.
▲ 3 upgrades / ▼ 0 downgrades / 5 reiterations from 7 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Oct 21, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Oct 21, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Oct 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Oct 20, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Oct 15, 2026 | UBS | initiate | — → Buy | — | 54% |
| Oct 15, 2026 | Wolfe Research | initiate | — → Outperform | — | 53% |
| Oct 6, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Sep 16, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 19, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 5, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 16, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 24, 2026 | Leerink Partners | initiate | — → Outperform | — | 50% |
| May 21, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 8, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Apr 22, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 11, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Mar 11, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Feb 2, 2026 | Wells Fargo | initiate | — → Overweight | $43 | 54% |
| Dec 9, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $40 | 44% |
| Dec 8, 2025 | BTIG | reiterate | Buy → Buy | $47 | 52% |
| Nov 19, 2025 | BTIG | initiate | — → Buy | $47 | 52% |
| Nov 7, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $80 | 46% |
| Sep 16, 2025 | Truist Securities | initiate | — → Buy | $44 | 54% |
| Sep 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $34 | 44% |
| Aug 6, 2025 | HC Wainwright & Co. | initiate | — → Buy | $31 | 44% |
| Jul 8, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $28 | 53% |
| Apr 8, 2025 | JMP Securities | initiate | — → Market Outperform | $28 | 53% |
| Oct 18, 2024 | Jones Trading | initiate | — → Buy | $42 | 50% |
| Jul 2, 2024 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Jul 2, 2024 | Jefferies | initiate | — → Buy | $35 | 52% |
| Jul 2, 2024 | Stifel | initiate | — → Buy | $35 | 54% |
No cross-platform signals in the last 90 days